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Background
Dendritic cells (DCs) present on the mucosa site are con-
sidered as one of the first target cells of HIV-1 following
sexual transmission. It has been demonstrated that imma-
ture DCs could transfer infectious HIV-1 particles to CD4
T-lymphocytes via a virological synapse in trans. The aim
of this study was to investigate the capacity of monoclonal
neutralizing antibodies to inhibit HIV-1 transfer from
immature DCs to CD4 T-lymphocytes.
Methods
Immature DCs were generated from purified human
blood monocytes. They were infected with HIV-1BaL for 2
hours and then washed extensively before exposure to
purified primary PHA-activated CD4 T-lymphocytes in
the presence or in the absence of monoclonal neutralizing
antibodies. At different time-points, the percentage of
HIV-infected DCs and CD4 T-lymphocytes were measured
by flow cytometry detection of intracellular viral p24 anti-
gen. The quantity of virus particles released in the super-
natant was determined by p24 ELISA.
Results
In the presence of CD4 T-lymphocytes, we found a strong
enhancement of the percentage of p24-positive immature
DCs. Monoclonal neutralizing IgG1b12, 2F5, 2G12 or
4E10 added 2 hours after infection of immature DCs
could totally inhibit HIV-1 replication in the CD4 T-lym-
phocytes. Nevertheless, due to the efficient HIV-1 replica-
tion in DCs in the presence of CD4 T-lymphocytes, HIV-1
p24 released in the supernatant of the co-culture was only
reduced in presence of antibodies.
Conclusion
Here we clearly demonstrated that neutralizing antibodies
are efficient inhibitors of HIV transfer to CD4 T lym-
phocytes and that HIV-1 replication becomes very effi-
cient in DCs when they are co-cultured with primary CD4
T-lymphocytes. These results suggest that antibodies
should thus be induced rapidly at the mucosal site to pre-
vent DC infection and transfer to CD4 T-lymphocytes.
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